Pro Feature
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moAMANTADINE (amantadine) by Supernus Pharmaceuticals is clinical pharmacology pharmacodynamics mechanism of action: antiviral the mechanism by which amantadine exerts its antiviral activity is not clearly understood. Approved for the treatment of parkinsonism, drug-induced extrapyramidal reactions, the treatment of uncomplicated respiratory tract illness caused by influenza a virus strains especially and 10 more indications. First approved in 2024.
Drug data last refreshed 19h ago
CLINICAL PHARMACOLOGY Pharmacodynamics Mechanism of Action: Antiviral The mechanism by which amantadine exerts its antiviral activity is not clearly understood. It appears to mainly prevent the release of infectious viral nucleic acid into the host cell by interfering with the function of the…
Worked on AMANTADINE at Supernus Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma
Effect of GOCOVRI (Amantadine, Extended Release Capsules) on Gait in Parkinson's Disease
Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia
Effect of Intravenous Amantadine on Gait Freezing in Parkinson's Disease
Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/mo